University of California San Diego at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
University of California San Diego brings 18 presentations to IDWeek 2026 in Washington. Its program centres on new ways to treat drug-resistant bacteria, from jumbo phages and cefiderocol to nanotherapies and nanovaccines, and on clofazimine for nontuberculous mycobacterial infections. It also reports a randomized trial of a host-directed antiviral for dengue and community outreach that raised RSV vaccine uptake.
| Organization | IDWeek 2026 Attendance |
|---|---|
University of California San Diego San Diego, CA | |
Talk Wed Oct 21 9:15am–9:30am Session Wed Oct 21 11:00am–11:25am RSV Prevention in Vulnerable Communities: From Understanding Barriers to Driving Action Respiratory infections and COVID-19Vaccines Session Wed Oct 21 1:30pm–3:15pm Mano-a-Mano HIV, sexually transmitted infections and viral hepatitis Poster Thu Oct 22 12:15pm–1:30pm Identifying the Bacterial Cell Surface Receptors of Nucleus-forming Jumbo Phages Session Thu Oct 22 3:15pm–4:30pm Controversies in Pneumonia Diagnosis and Treatment Respiratory infections and COVID-19Antimicrobials, resistance and stewardship Session Thu Oct 22 3:15pm–4:30pm Implant or Invader? Device-Associated Infection Surveillance & Prevention Infection prevention and healthcare epidemiology Talk Thu Oct 22 3:40pm–4:05pm Corticosteroids in Severe Community-Acquired Pneumonia: Help or Harm? Respiratory infections and COVID-19Antimicrobials, resistance and stewardship Poster Fri Oct 23 12:15pm–1:30pm Cefiderocol Exhibits Enhanced Activity and Host-Synergistic Effects Under Physiologic Conditions Against Multidrug-Resistant Gram-Negative Pathogens Poster Fri Oct 23 12:15pm–1:30pm Clofazimine Use in Non-Tuberculous Mycobacteria (NTM) Lung Infections Poster Fri Oct 23 12:15pm–1:30pm Clofazimine as Adjunctive Therapy for Challenging Extrapulmonary Nontuberculous Mycobacterial Infections Industry Fri Oct 23 1:15pm–2:00pm A yeast of burden: managing Candida auris in healthcare Infection prevention and healthcare epidemiology Talk Sat Oct 24 11:20am–11:45am Poster Sat Oct 24 12:15pm–1:30pm A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Trial of CP-COV03, a Host-Directed Antiviral for Dengue and Dengue-like Illnesses Poster Sat Oct 24 12:15pm–1:30pm Behavioral Health Engagement in Patients with HIV, Chronic Hepatitis B and Long COVID in an Integrated Primary Care Setting Poster Sat Oct 24 12:15pm–1:30pm Community-Based Education and Warm Handoffs to Vaccinators Improve RSV Vaccine Confidence and Uptake Poster Sat Oct 24 12:15pm–1:30pm T cell response to SARS-CoV-2 vaccination across pediatric age groups as compared to adults Talk Sat Oct 24 3:15pm–3:40pm Novel Biomimetic Nanotherapies and Nanovaccines for Leading AMR Pathogens Transplant and immunocompromised hostsAntimicrobials, resistance and stewardshipVaccines Session Sat Oct 24 3:15pm–4:30pm Upcoming Therapeutics and Diagnostics, Integrated Solutions for Infectious Threats Transplant and immunocompromised hostsAntimicrobials, resistance and stewardshipDiagnostics and diagnostic stewardship |
Instantly find 20 buyers from University of California San Diego
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction